Literature DB >> 6150295

Ketoconazole and cholesterol synthesis.

T A Miettinen, V V Valtonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6150295     DOI： 10.1016/s0140-6736(84)92814-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  The endocrine effects of ketoconazole.

Authors:  N Sonino
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

2.  Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects.

Authors:  I D Bradbrook; H C Gillies; P J Morrison; J Robinson; H J Rogers; R G Spector
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

3.  Inhibition and induction of bile acid synthesis by ketoconazole. Effects on bile formation in the rat.

Authors:  F Kuipers; R Havinga; C M Huijsmans; R J Vonk; H M Princen
Journal:  Lipids       Date:  1989-09       Impact factor: 1.880

4.  Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole.

Authors:  Y A Kesäniemi; T A Miettinen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

5.  Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase.

Authors:  H M Princen; C M Huijsmans; F Kuipers; R J Vonk; H J Kempen
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

6.  Ketoconazole in experimental vaginal candidosis in rats.

Authors:  O S Kinsman; A E Collard; T J Savage
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

7.  Effects of ketoconazole on cholesterol synthesis and precursor concentrations in the rat liver.

Authors:  T E Strandberg; R S Tilvis; T A Miettinen
Journal:  Lipids       Date:  1987-12       Impact factor: 1.880
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.